Sarah Maddocks

Dr. Sarah Maddocks

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2018 in Pathogens and Disease
Verified
Journal Article
Open access
PDF file
PAPatrícia M Alves
Patrícia M Alves
EAEida Al-Badi
Eida Al-Badi
CWCathryn Withycombe
Cathryn Withycombe
PJPaul M Jones
Paul M Jones
KPKevin J Purdy
Kevin J Purdy
SMSarah Maddocks
Sarah Maddocks
Debate regarding the co-existence of Staphylococcus aureus and Pseudomonas aeruginosa in wounds remains contentious, with the dominant hypothesis describing a situation akin to niche partitioning, whereby both microorganisms are present but occupy distinct regions of the wound without interacting. In contrast, we hypothesised that these microorganisms do interact during early co-colonisation in a manner beneficial to both bacteria. We assessed competitive interaction between S. aureus and P. aeruginosa in biofilm cultured for 24–72 h and bacterial aggregates analogous to those observed in early (<24 h) biofilm formation, and interaction with human keratinocytes. We observed that S. aureus predominated in biofilm and non-attached bacterial aggregates, acting as a pioneer for the attachment of P. aeruginosa. We report for the first time that S. aureus mediates a significant (P < 0.05) increase in the attachment of P. aeruginosa to human keratinocytes, and that P. aeruginosa promotes an invasive phenotype in S. aureus. We show that co-infected keratinocytes exhibit an intermediate inflammatory response concurrent with impaired wound closure that is in keeping with a sustained proinflammatory response which allows for persistent microbial colonisation. These studies demonstrate that, contrary to the dominant hypothesis, interactions between S. aureus and P. aeruginosa may be an important factor for both colonisation and pathogenicity in the chronic infected wound.

1 December 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
HTHajer Taleb
Hajer Taleb
SMSarah Maddocks
Sarah Maddocks
RMR. Keith Morris
R. Keith Morris
AKAra D. Kanekanian
Ara D. Kanekanian
Date fruit, Phoenix dactylifera L. has traditionally been used as a medicine in many cultures for the treatment of a range of ailments such as stomach and intestinal disorders, fever, oedema, bronchitis and wound healing. The present review aims to summarise the traditional use and application of P. dactylifera date fruit in different ethnomedical systems, additionally the botany and phytochemistry are identified. Critical evaluation of in vitro and in vitro studies examining date fruit in relation to anti-inflammatory, anti-angiogenic and antimicrobial activities are outlined. The ethnomedical use of P. dactylifera in the treatment of inflammatory disease has been previously identified and reported. Furthermore, date fruit and date fruit co-products such as date syrup are rich sources of polyphenols, anthocyanins, sterols and carotenoids. In vitro studies have demonstrated that date fruit exhibits antibacterial, anti-inflammatory and anti-angiogenic activity. The recent interest in the identification of the numerous health benefits of dates using in vitro and in vivo studies have confirmed that date fruit and date syrup have beneficial health effects that can be attributed to the presence of natural bioactive compounds. Date fruit and date syrup have therapeutic properties, which have the potential to be beneficial to health. However, more investigations are needed to quantify and validate these effects.

1 January 2015 in Microbiology Insights
Verified
Journal Article
Open access
BJBenjamin E. Johns
Benjamin E. Johns
KPKevin J. Purdy
Kevin J. Purdy
NTNicholas P. Tucker
Nicholas P. Tucker
SMSarah Maddocks
Sarah Maddocks
Small colony variant (SCV) bacteria arise spontaneously within apparently homogeneous microbial populations, largely in response to environmental stresses, such as antimicrobial treatment. They display unique phenotypic characteristics conferred in part by heritable genetic changes. Characteristically slow growing, SCVs comprise a minor proportion of the population from which they arise but persist by virtue of their inherent resilience and host adaptability. Consequently, SCVs are problematic in chronic infection, where antimicrobial treatment is administered during the acute phase of infection but fails to eradicate SCVs, which remain within the host causing recurrent or chronic infection. This review discusses some of the phenotypic and genotypic changes that enable SCVs to successfully proliferate within the host environment as potential pathogens and strategies that could ameliorate the resolution of infection where SCVs are present.

26 February 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
HTHajer Taleb
Hajer Taleb
SMSarah Maddocks
Sarah Maddocks
RMR. Keith Morris
R. Keith Morris
AKAra D. Kanekanian
Ara D. Kanekanian
The increase in antibiotic-resistant bacteria poses a threat to health care worldwide; this has resulted in a revived interest in plant products as adjunct antimicrobial agents to control pathogenic microorganisms. A major plant group used for traditional medicinal applications is Phoenix Dactylifera L, more commonly known as the date palm. Fruit of the date palm have been used customarily in the treatment of intestinal disturbances, hypertension, oedema and gastrointestinal disease, the nomadic tribes in the Middle East have been known to use traditional date syrup as an antimicrobial agent for wound healing. In some cases these ailments can be attributed to or are strongly associated with a variety of bacterial infections and inflammation. Plant-derived products such as date syrup have demonstrated antibacterial activity and can inhibit bacteria through numerous different mechanisms, which may be attributed to bioactive compounds including plant-derived phenolic molecules. Many such products derive their inherent antimicrobial activity from the presence of polyphenols, which cause oxidative damage. This investigation demonstrated that date syrup, and polyphenols extracted from date syrup, the most abundant bioactive constituent of date syrup are bacteriostatic to both Gram positive and Gram negative Escherichia coli and Staphylococcus aureus. We have further shown that the extracted polyphenols independently suppress the growth of bacteria and have observed that date syrup behaves as a prooxidant by generating hydrogen peroxide that mediates bacterial growth inhibition as a result of oxidative stress. at sub-lethal MIC concentrations date syrup demonstrated antioxidative activity by reducing hydrogen peroxide, and at lethal concentrations date syrup demonstrated prooxidant activity that inhibited the growth of E. coli and S. aureus. The high sugar content naturally present in date syrup did not significantly contribute to this effect. These findings highlight that date syrup’s antimicrobial activity is mediated through hydrogen peroxide generation in inducing oxidative stress in bacteria.

1 October 2018 in Microbiological Research
Verified
Journal Article
Closed access
PDPeter F. Duckworth
Peter F. Duckworth
RRRichard S. Rowlands
Richard S. Rowlands
MBMichele E. Barbour
Michele E. Barbour
SMSarah Maddocks
Sarah Maddocks

1 January 2014 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
ACAimee L Camplin
Aimee L Camplin
SMSarah Maddocks
Sarah Maddocks
Medical grade manuka honeys are well known to be efficacious against Pseudomonas aeruginosa being bactericidal and inhibiting the development of biofilms; moreover manuka honey effectively kills P. aeruginosa embedded within an established biofilm. Sustained honey resistance has not been previously documented for planktonic or biofilm P. aeruginosa.